Daily FNArena News - Small Caps

Stem cell developer Cynata Technologies has found a fan in Baillieu Holst because of the potential to revolutionise regenerative medicine.

Thorn Group is showing signs of growth after flatlining in recent years but brokers are reserving judgement.

Select Harvests has been troubled by rainfall as it harvests the almond crop but strong prices provide an offset.

Brokers consider Virtus Health has good growth potential, supported by changing demographics.

Brokers take a closer look at Vocus Communications and the trajectory for its dark fibre.

Rare earth producer Lynas Corp has averted a cash shortage for now with a planned equity raising and debt restructure.

Atlas Iron has outlined a plan to create a mining hub at Corunna Downs but brokers are more concerned about the sustainability of the iron ore price.

Drug developer QRxPharma has been set back by the US FDA advisory committee’s rejection of MoxDuo-IR.

Circuit board designer Altium has impressed brokers with its earnings growth potential.

Brokers are increasingly confident the newly listed Dick Smith can deliver sustainable earnings growth.